Effect of acute and chronic treatment with triiodothyronine on serotonin levels and serotonergic receptor subtypes in the rat brain

被引:53
作者
Sandrini, M
Vitale, G
Vergoni, AV
Ottani, A
Bertolini, A
机构
[1] Department of Biomedical Sciences, Section of Pharmacology, University of Modena, I-41100 Modena
[2] Dept. of Biomedical Sci., Sect. of Pharmacology, Univ. of Modena, I-41100 Modena Mo
关键词
triiodothyronine; 5-HT; brain;
D O I
10.1016/0024-3205(96)00129-4
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Hyperthyroidism is often associated with behavioral disorders, and thyroid hormones modify receptor sensitivity as well as the synthesis and/or turnover rate of many neurotransmitters. We evaluated the influence in adult rats of triiodothyronine (T-3), administred s.c. (100 mu g/kg) acutely (once only) or chronically (once a day for 3 or 7 consecutive days), on brain serotonin concentration and on the density and affinity of two brain serotonin (5-HT) receptor subtypes mainly involved in behavioral effects. After both acute and chronic T-3 treatment, serotonin levels increased in the cerebral cortex but not in the hippocampus. The density and affinity of 5-HT1A receptors (using [H-3]-8-OH-DPAT as ligand) were not affected, while there was a significant decrease in the number of 5-HT2 receptors in the cerebral cortex (using [H-3]ketanserin as ligand). This observation might indicate that thyroid hormones enhance 5-HT concentration in certain brain areas, thus causing a down-regulation of 5-HT2 receptors. The serotonergic system could be involved in the complex brain-neurotransmitter imbalance underlying hyperthyroidism-linked behavioral changes.
引用
收藏
页码:1551 / 1559
页数:9
相关论文
共 49 条
[1]   GEPIRONE, A SELECTIVE SEROTONIN (5HT(1A)) PARTIAL AGONIST IN THE TREATMENT OF MAJOR DEPRESSION [J].
AMSTERDAM, JD .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1992, 16 (03) :271-280
[2]   5-HT1A RECEPTORS IN THE MEDIAN RAPHE NUCLEUS AND DORSAL HIPPOCAMPUS MAY MEDIATE ANXIOLYTIC AND ANXIOGENIC BEHAVIORS RESPECTIVELY [J].
ANDREWS, N ;
HOGG, S ;
GONZALEZ, LE ;
FILE, SE .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 264 (03) :259-264
[3]  
[Anonymous], CURRENT DRUGS SEROTO
[4]   FACILITATION OF 8-OHDPAT-INDUCED FOREPAW TREADING OF RATS BY THE 5-HT2 AGONIST DOI [J].
ARNT, J ;
HYTTEL, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 161 (01) :45-51
[5]   EFFECT OF ACUTE AND CHRONIC TRI-IODOTHYRONINE (T3) ADMINISTRATION TO RATS ON CENTRAL 5-HT AND DOPAMINE-MEDIATED BEHAVIORAL-RESPONSES AND RELATED BRAIN BIOCHEMISTRY [J].
ATTERWILL, CK .
NEUROPHARMACOLOGY, 1981, 20 (02) :131-144
[6]  
ATTERWILL CK, 1984, J NEURAL TRANSM, V59, P43, DOI 10.1007/BF01249877
[7]  
AZAM M, 1990, BIOCHEM INT, V20, P1141
[8]   BEHAVIORAL EVIDENCE FOR A FUNCTIONAL INTERACTION BETWEEN CENTRAL 5-HT2-RECEPTOR AND 5-HT1A-RECEPTOR [J].
BACKUS, LI ;
SHARP, T ;
GRAHAMESMITH, DG .
BRITISH JOURNAL OF PHARMACOLOGY, 1990, 100 (04) :793-799
[9]   L-694,247 - A POTENT 5-HT(1D) RECEPTOR AGONIST [J].
BEER, MS ;
STANTON, JA ;
BEVAN, Y ;
HEALD, A ;
REEVE, AJ ;
STREET, LJ ;
MATASSA, VG ;
HARGREAVES, RJ ;
MIDDLEMISS, DN .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 110 (03) :1196-1200
[10]   EFFECTS OF TRIIODOTHYRONINE ON THE 5-HYDROXYTRYPTOPHAN-INDUCED HEAD TWITCH AND ITS POTENTIATION BY ANTIDEPRESSANTS IN MICE [J].
BROCHET, D ;
MARTIN, P ;
SOUBRIE, P ;
SIMON, P .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 112 (03) :411-414